DHI Price To Sales Ratio vs Interest Coverage Analysis
DHI Stock | USD 168.78 0.65 0.38% |
DR Horton financial indicator trend analysis is much more than just examining DR Horton latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DR Horton is a good investment. Please check the relationship between DR Horton Price To Sales Ratio and its Interest Coverage accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.
Price To Sales Ratio vs Interest Coverage
Price To Sales Ratio vs Interest Coverage Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DR Horton Price To Sales Ratio account and Interest Coverage. At this time, the significance of the direction appears to have weak relationship.
The correlation between DR Horton's Price To Sales Ratio and Interest Coverage is 0.36. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Interest Coverage in the same time period over historical financial statements of DR Horton, assuming nothing else is changed. The correlation between historical values of DR Horton's Price To Sales Ratio and Interest Coverage is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of DR Horton are associated (or correlated) with its Interest Coverage. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Coverage has no effect on the direction of Price To Sales Ratio i.e., DR Horton's Price To Sales Ratio and Interest Coverage go up and down completely randomly.
Correlation Coefficient | 0.36 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing DR Horton stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on DR Horton sales, a figure that is much harder to manipulate than other DR Horton multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Interest Coverage
Most indicators from DR Horton's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DR Horton current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.As of now, DR Horton's Enterprise Value Multiple is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 10.5B | 9.4B | 9.5B | 10.0B | Total Revenue | 33.5B | 35.5B | 36.8B | 38.6B |
DR Horton fundamental ratios Correlations
Click cells to compare fundamentals
DR Horton Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DR Horton fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 18.9B | 24.0B | 30.4B | 32.6B | 36.1B | 37.9B | |
Short Long Term Debt Total | 4.3B | 5.4B | 6.1B | 5.1B | 5.9B | 3.9B | |
Total Current Liabilities | 2.5B | 3.4B | 4.5B | 4.4B | 7.3B | 7.6B | |
Total Stockholder Equity | 11.8B | 14.9B | 19.4B | 22.7B | 25.3B | 26.6B | |
Property Plant And Equipment Net | 683.7M | 114.6M | 152.8M | 445.4M | 531M | 557.6M | |
Net Debt | 1.3B | 2.2B | 3.5B | 1.2B | 1.5B | 1.9B | |
Retained Earnings | 9.8B | 13.6B | 19.2B | 23.6B | 28.0B | 29.3B | |
Accounts Payable | 900.5M | 1.2B | 1.4B | 1.2B | 1.3B | 1.4B | |
Cash | 3.0B | 3.2B | 2.5B | 3.9B | 4.5B | 4.7B | |
Non Current Assets Total | 2.1B | 2.3B | 3.7B | 3.8B | 694.5M | 1.3B | |
Non Currrent Assets Other | (688.5M) | 1.6B | 515.2M | 3.4B | (167.5M) | (159.1M) | |
Cash And Short Term Investments | 3.0B | 3.2B | 2.5B | 3.9B | 4.5B | 4.7B | |
Common Stock Shares Outstanding | 370.2M | 365.8M | 354.8M | 343.3M | 331.6M | 322.0M | |
Liabilities And Stockholders Equity | 18.9B | 24.0B | 30.4B | 32.6B | 36.1B | 37.9B | |
Non Current Liabilities Total | 4.3B | 5.4B | 6.1B | 5.1B | 8.2B | 8.7B | |
Inventory | 12.2B | 16.5B | 21.7B | 22.4B | 24.9B | 26.1B | |
Other Current Assets | 1.3B | 1.7B | 4.2B | 2.1B | 2.5B | 2.6B | |
Other Stockholder Equity | 2.1B | 1.2B | 207M | (897.6M) | (2.6B) | (2.5B) | |
Total Liab | 6.8B | 8.8B | 10.6B | 9.4B | 10.3B | 10.8B | |
Property Plant And Equipment Gross | 104.4M | 114.6M | 152.8M | 64.6M | 70M | 120.0M | |
Total Current Assets | 16.8B | 21.7B | 26.6B | 28.8B | 29.4B | 30.9B | |
Short Term Debt | 4.3B | 5.4B | 6.1B | 5.1B | 5.9B | 3.0B | |
Other Current Liab | (2.8B) | (3.4B) | (3.2B) | 3.1B | 5.8B | 6.1B | |
Other Assets | 201M | 5.1B | 5.4B | 213.7M | 6.0B | 6.3B | |
Long Term Debt | 4.3B | 5.4B | 6.1B | 5.1B | 5.9B | 3.7B | |
Treasury Stock | (802.2M) | (1.2B) | (2.0B) | (3.1B) | (2.8B) | (2.7B) | |
Property Plant Equipment | 683.7M | 392.9M | 471.6M | 445.4M | 512.2M | 537.8M | |
Other Liab | 685.5M | 871.3M | 1.3B | 1.2B | 1.0B | 618.4M | |
Current Deferred Revenue | 93.1M | 193.4M | 224.2M | (5.1B) | (4.6B) | (4.4B) | |
Net Receivables | 271.4M | 321.7M | 423.1M | 426.9M | 421.4M | 293.3M | |
Net Tangible Assets | 11.7B | 14.7B | 19.2B | 22.5B | 25.9B | 27.2B |
Currently Active Assets on Macroaxis
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 1.2 | Earnings Share 14.33 | Revenue Per Share 111.689 | Quarterly Revenue Growth (0.05) |
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.